Clinical Trials Directory

Trials / Completed

CompletedNCT02376738

Regional Activation of Leukocytes in Coronary Artery Disease

Status
Completed
Phase
Study type
Observational
Enrollment
97 (actual)
Sponsor
Sint Franciscus Gasthuis · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the role of leukocyte activation in coronary artery disease

Detailed description

1. The primary aim of REAL CAD is to determine regional differences of leukocyte activation in different vascular beds in vivo. 2. The secondary aim is to investigate differences in leukocyte activation between diabetic and CAD subjects and patients suffering from both. 3. The third aim is to investigate the relationship between complement components, triglycerides and leukocyte activation markers in order to gain more insight into the causative processes leading to activation of leukocytes. 4. The fourth aim is to get more insight in the MBL genotypes and serum levels of CAD and/or diabetic patients and the 'healthy' groups included in our study.

Conditions

Timeline

Start date
2007-07-01
Primary completion
2008-09-01
Completion
2008-09-01
First posted
2015-03-03
Last updated
2015-03-03

Locations

2 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02376738. Inclusion in this directory is not an endorsement.

Regional Activation of Leukocytes in Coronary Artery Disease (NCT02376738) · Clinical Trials Directory